Loading organizations...
PeakData is a technology company.
PeakData provides AI-driven insights and analytics specifically for the pharmaceutical industry. Its core product delivers actionable intelligence, helping pharma clients understand and engage key stakeholders throughout the product lifecycle. The platform processes extensive data to identify relevant trends, enabling precise and impactful decision-making within complex healthcare environments.
Established in 2018 by Michael Feldman and Patrick de Boer, PeakData emerged from the critical need for advanced data intelligence within the global pharmaceutical sector. The co-founders observed inefficiencies in understanding influential healthcare professionals and market dynamics. Their insight focused on leveraging artificial intelligence to transform how pharma companies approach market analysis and stakeholder engagement.
PeakData serves leading pharmaceutical companies globally, assisting them in navigating intricate market landscapes and improving strategic outreach. The platform supports these organizations in enhancing commercial strategies and scientific communication. The company’s mission fosters a world where patients receive optimal care by empowering pharmaceutical companies with essential insights.
PeakData has raised $12.0M across 1 funding round.
PeakData has raised $12.0M in total across 1 funding round.
PeakData has raised $12.0M in total across 1 funding round.
PeakData's investors include Albion VC, Amino Collective, Heal Capital, Octopus Ventures.
PeakData is a technology company founded in 2018 that provides AI-driven insights and analytics specifically for the pharmaceutical industry. Its core product is an agile targeting and segmentation platform that helps pharmaceutical companies better understand and engage healthcare professionals (HCPs) by mapping their digital impact, influence, and research interests. PeakData serves major pharmaceutical clients by enabling more precise customer targeting, improving resource allocation, and enhancing scientific meeting programs through peer-to-peer HCP network insights. This technology addresses the challenge of identifying and engaging hard-to-reach HCPs, ultimately supporting pharmaceutical companies in delivering innovative medicines more effectively[1][2][3][4].
PeakData was founded in 2018 by Patrick, a scientist and data engineer with over 13 years of experience, including a role as CTO at MIT’s Center for Collective Intelligence. His passion for sustainability and data-driven solutions inspired the creation of PeakData’s AI-powered analytics platform. Sebastian, a healthcare executive with over 20 years of experience in pharmaceutical business and product launches, joined to help apply AI technology to real-world pharma use cases. The company’s early traction came from developing a unique approach that combines big data analytics and AI to create ranked healthcare professional profiles, which has been well received by global pharmaceutical clients[1].
PeakData rides the growing trend of AI and big data analytics transforming pharmaceutical marketing and medical affairs. The timing is critical as pharma companies increasingly seek data-driven methods to navigate complex healthcare ecosystems and personalize communication with healthcare professionals. Market forces such as digital transformation in healthcare, rising demand for precision targeting, and the need for real-time insights favor PeakData’s solutions. By enabling pharma companies to identify influential HCPs and optimize engagement strategies, PeakData contributes to accelerating the adoption of innovative medicines and improving patient outcomes[1][2][3].
Looking ahead, PeakData is well-positioned to expand its influence by deepening AI capabilities and broadening its platform coverage across more therapeutic areas and geographies. Trends such as increased digital engagement by healthcare professionals and the pharmaceutical industry's growing reliance on AI-driven insights will shape its journey. PeakData’s continued innovation in mapping HCP networks and delivering actionable, real-time data will likely enhance its role as a critical partner for pharma companies aiming to improve medical affairs effectiveness and patient impact. Its mission to empower data-driven decisions aligns with the broader shift toward personalized healthcare and smarter commercial strategies[1][3][4].
PeakData has raised $12.0M across 1 funding round. Most recently, it raised $12.0M Series A in August 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2022 | $12.0M Series A | Albion VC | Amino Collective, Heal Capital, Octopus Ventures |